Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Accumulation of di-2-ethylhexyl phthalate from polyvinyl chloride flooring into settled house dust and the effect on the bacterial community.

Velazquez S, Bi C, Kline J, Nunez S, Corsi R, Xu Y, Ishaq SL.

PeerJ. 2019 Nov 22;7:e8147. doi: 10.7717/peerj.8147. eCollection 2019.

2.

Unique Pharmacokinetics of Buprenorphine During Pregnancy.

Hollabaugh CR, Donovan B, Velazquez S, Sethi R.

Prim Care Companion CNS Disord. 2019 Oct 17;21(5). pii: 18l02390. doi: 10.4088/PCC.18l02390. No abstract available.

3.

From one species to another: A review on the interaction between chemistry and microbiology in relation to cleaning in the built environment.

Velazquez S, Griffiths W, Dietz L, Horve P, Nunez S, Hu J, Shen J, Fretz M, Bi C, Xu Y, Van Den Wymelenberg KG, Hartmann EM, Ishaq SL.

Indoor Air. 2019 Nov;29(6):880-894. doi: 10.1111/ina.12596. Epub 2019 Sep 6. Review.

4.

Water recovery by treatment of food industry wastewater using membrane processes.

Hernández K, Muro C, Ortega RE, Velazquez S, Riera F.

Environ Technol. 2019 Jul 25:1-14. doi: 10.1080/09593330.2019.1645739. [Epub ahead of print]

PMID:
31313652
5.

Pyrrolopyrimidine vs Imidazole-Phenyl-Thiazole Scaffolds in Nonpeptidic Dimerization Inhibitors of Leishmania infantum Trypanothione Reductase.

Revuelto A, Ruiz-Santaquiteria M, de Lucio H, Gamo A, Carriles AA, Gutiérrez KJ, Sánchez-Murcia PA, Hermoso JA, Gago F, Camarasa MJ, Jiménez-Ruiz A, Velázquez S.

ACS Infect Dis. 2019 Jun 14;5(6):873-891. doi: 10.1021/acsinfecdis.8b00355. Epub 2019 Apr 23.

PMID:
30983322
6.

10-MV SBRT FFF IRRADIATION TECHNIQUE IS ASSOCIATED TO THE LOWEST PERIPHERAL DOSE: THE OUTCOME OF 142 TREATMENT PLANS FOR THE 10 MOST COMMON TUMOUR LOCATIONS.

Irazola L, Sánchez-Nieto B, García-Hernández MT, Terrón JA, Roselló J, Ortiz-Seidel M, Béjar MJ, Linares R, Vélazquez S, Sánchez-Doblado F.

Radiat Prot Dosimetry. 2019 Jan 11. doi: 10.1093/rpd/ncy292. [Epub ahead of print]

PMID:
30649534
7.

Trypanothione reductase inhibition and anti-leishmanial activity of all-hydrocarbon stapled α-helical peptides with improved proteolytic stability.

Ruiz-Santaquiteria M, de Castro S, Toro MA, de Lucio H, Gutiérrez KJ, Sánchez-Murcia PA, Jiménez MÁ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.

Eur J Med Chem. 2018 Apr 10;149:238-247. doi: 10.1016/j.ejmech.2018.02.071. Epub 2018 Feb 24.

PMID:
29501944
8.

Improved proteolytic stability and potent activity against Leishmania infantum trypanothione reductase of α/β-peptide foldamers conjugated to cell-penetrating peptides.

de Lucio H, Gamo AM, Ruiz-Santaquiteria M, de Castro S, Sánchez-Murcia PA, Toro MA, Gutiérrez KJ, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.

Eur J Med Chem. 2017 Nov 10;140:615-623. doi: 10.1016/j.ejmech.2017.09.032. Epub 2017 Sep 21.

PMID:
29017116
9.

Evaluation of nutrients removal (NO3-N, NH3-N and PO4-P) with Chlorella vulgaris, Pseudomonas putida, Bacillus cereus and a consortium of these microorganisms in the treatment of wastewater effluents.

Gómez-Guzmán A, Jiménez-Magaña S, Guerra-Rentería AS, Gómez-Hermosillo C, Parra-Rodríguez FJ, Velázquez S, Aguilar-Uscanga BR, Solis-Pacheco J, González-Reynoso O.

Water Sci Technol. 2017 Jul;76(1-2):49-56. doi: 10.2166/wst.2017.175.

PMID:
28708609
10.

First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in vitro antileishmanial activity.

Ruiz-Santaquiteria M, Sánchez-Murcia PA, Toro MA, de Lucio H, Gutiérrez KJ, de Castro S, Carneiro FAC, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.

Eur J Med Chem. 2017 Jul 28;135:49-59. doi: 10.1016/j.ejmech.2017.04.020. Epub 2017 Apr 13.

11.

Correction: 3D VMAT Verification Based on Monte Carlo Log File Simulation with Experimental Feedback from Film Dosimetry.

Barbeiro AR, Ureba A, Baeza JA, Linares R, Perucha M, Jiménez-Ortega E, Velázquez S, Mateos JC, Leal A.

PLoS One. 2017 Feb 13;12(2):e0172378. doi: 10.1371/journal.pone.0172378. eCollection 2017.

12.

3D VMAT Verification Based on Monte Carlo Log File Simulation with Experimental Feedback from Film Dosimetry.

Barbeiro AR, Ureba A, Baeza JA, Linares R, Perucha M, Jiménez-Ortega E, Velázquez S, Mateos JC, Leal A.

PLoS One. 2016 Nov 21;11(11):e0166767. doi: 10.1371/journal.pone.0166767. eCollection 2016. Erratum in: PLoS One. 2017 Feb 13;12 (2):e0172378.

13.

Antivascular and antitumor properties of the tubulin-binding chalcone TUB091.

Canela MD, Noppen S, Bueno O, Prota AE, Bargsten K, Sáez-Calvo G, Jimeno ML, Benkheil M, Ribatti D, Velázquez S, Camarasa MJ, Díaz JF, Steinmetz MO, Priego EM, Pérez-Pérez MJ, Liekens S.

Oncotarget. 2017 Feb 28;8(9):14325-14342. doi: 10.18632/oncotarget.9527.

14.

Dipeptidyl-peptidase IV (DPP IV/CD26)-activated prodrugs: a successful strategy for improving water solubility and oral bioavailability.

Velázquez S, de Castro S, Diez-Torrubia A, Balzarini J, Camarasa MJ.

Curr Med Chem. 2015;22(8):1041-54. Review.

PMID:
25620096
15.

Assessment of Pozzolanic Activity Using Methods Based on the Measurement of Electrical Conductivity of Suspensions of Portland Cement and Pozzolan.

Velázquez S, Monzó JM, Borrachero MV, Payá J.

Materials (Basel). 2014 Nov 21;7(11):7533-7547. doi: 10.3390/ma7117533.

16.

Discovery and SAR studies of a novel class of cytotoxic 1,4-disubstituted piperidines via Ugi reaction.

de Castro S, Camarasa MJ, Balzarini J, Velázquez S.

Eur J Med Chem. 2014 Aug 18;83:174-89. doi: 10.1016/j.ejmech.2014.06.026. Epub 2014 Jun 13.

PMID:
24956554
17.

Assessment of the Pozzolanic Activity of a Spent Catalyst by Conductivity Measurement of Aqueous Suspensions with Calcium Hydroxide.

Velázquez S, Monzó JM, Borrachero MV, Payá J.

Materials (Basel). 2014 Mar 28;7(4):2561-2576. doi: 10.3390/ma7042561.

18.

Novel water-soluble prodrugs of acyclovir cleavable by the dipeptidyl-peptidase IV (DPP IV/CD26) enzyme.

Diez-Torrubia A, Cabrera S, de Castro S, García-Aparicio C, Mulder G, De Meester I, Camarasa MJ, Balzarini J, Velázquez S.

Eur J Med Chem. 2013;70:456-68. doi: 10.1016/j.ejmech.2013.10.001. Epub 2013 Oct 9.

PMID:
24185376
19.

Probing the dimerization interface of Leishmania infantum trypanothione reductase with site-directed mutagenesis and short peptides.

Toro MA, Sánchez-Murcia PA, Moreno D, Ruiz-Santaquiteria M, Alzate JF, Negri A, Camarasa MJ, Gago F, Velázquez S, Jiménez-Ruiz A.

Chembiochem. 2013 Jul 8;14(10):1212-7. doi: 10.1002/cbic.201200744. Epub 2013 Jun 6.

PMID:
23744811
20.

The importance of both workplace and private life factors in psychological distress: a large cross-sectional survey of French railway company employees.

Evans D, Mallet L, Flahault A, Cothereau C, Velazquez S, Capron L, Lejoyeux M.

Soc Psychiatry Psychiatr Epidemiol. 2013 Aug;48(8):1211-24. doi: 10.1007/s00127-012-0605-7. Epub 2012 Oct 21.

PMID:
23086586
21.

Dipeptidyl peptidase IV-activated prodrugs of anti-varicella zoster virus bicyclic nucleoside analogues containing different self-cleavage spacer systems.

Diez-Torrubia A, Cabrera S, De Meester I, Camarasa MJ, Balzarini J, Velázquez S.

ChemMedChem. 2012 Sep;7(9):1612-22. doi: 10.1002/cmdc.201200295. Epub 2012 Aug 6.

PMID:
22887971
22.

Dipeptidyl peptidase IV (DPPIV/CD26)-based prodrugs of hydroxy-containing drugs.

Diez-Torrubia A, Cabrera S, Lambeir AM, Balzarini J, Camarasa MJ, Velázquez S.

ChemMedChem. 2012 Apr;7(4):618-28. doi: 10.1002/cmdc.201100504. Epub 2012 Feb 3.

PMID:
22307932
23.

Identification of nonlinear cardiac cell dynamics using radial basis function regression.

Kanaan-Izquierdo S, Velazquez S, Benitez R.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:6833-6. doi: 10.1109/IEMBS.2011.6091685.

PMID:
22255908
24.

From β-amino-γ-sultone to unusual bicyclic pyridine and pyrazine heterocyclic systems: synthesis and cytostatic and antiviral activities.

de Castro S, Familiar O, Andrei G, Snoeck R, Balzarini J, Camarasa MJ, Velázquez S.

ChemMedChem. 2011 Apr 4;6(4):686-97. doi: 10.1002/cmdc.201000546. Epub 2011 Mar 2.

PMID:
21370477
25.

Dipeptidyl peptidase IV dependent water-soluble prodrugs of highly lipophilic bicyclic nucleoside analogues.

Diez-Torrubia A, Balzarini J, Andrei G, Snoeck R, De Meester I, Camarasa MJ, Velázquez S.

J Med Chem. 2011 Mar 24;54(6):1927-42. doi: 10.1021/jm101624e. Epub 2011 Feb 18.

PMID:
21332170
27.

Application of the dipeptidyl peptidase IV (DPPIV/CD26) based prodrug approach to different amine-containing drugs.

Diez-Torrubia A, García-Aparicio C, Cabrera S, De Meester I, Balzarini J, Camarasa MJ, Velázquez S.

J Med Chem. 2010 Jan 28;53(2):559-72. doi: 10.1021/jm901590f.

PMID:
20000418
28.

Emerging issues at the intersection of immigration and child welfare: results from a transnational research and policy forum.

Dettlaff AJ, Vidal de Haymes M, Velazquez S, Mindell R, Bruce L.

Child Welfare. 2009;88(2):47-67.

PMID:
19777792
29.

4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.

De Castro S, García-Aparicio C, Andrei G, Snoeck R, Balzarini J, Camarasa MJ, Velázquez S.

J Med Chem. 2009 Mar 26;52(6):1582-91. doi: 10.1021/jm8014662. Erratum in: J Med Chem. 2009 May 14;52(9):3121.

PMID:
19226140
30.

Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR).

Olivares JM, Rodriguez-Morales A, Diels J, Povey M, Jacobs A, Zhao Z, Lam A, Villalobos Vega JC, Cuéllar JA, de Castro FJ, Quintero CM, Martíin JF, Domínguez P, Ojeda JL, Cortés SS, Cala FI, Marín CG, Castro LM, Duaso MA, Albarracín JR, Vergara GN, Benítez AF, Cleries FM, Pérez-Brian JM, Aragón AB, Navarro JC, Biedma JA, de Pedro RB, González JF, López ME, Moreno HD, López JA, Rodríguez EO, de Hoyos CM, Sacristán MP, Martín MD, Ballesteros EM, Rodríguez PA, Menéndez LF, Rivas RS, del Pino Cuadrado P, Lauffer JC, Solano JJ, Martínez JM, Solano FG, Rodríguez PG, Rodríguez JA, Cano TR, Fortacin MD, Lobeiras JM, Sampedro JM, Bravo AP, Pellicer AF, López MD, Liste JF, Fernández MR, Losada AC, Mendez RV, Romero SA, Blanco JJ, Bonaselt IT, Mahia MC, del Valle EF, Yañez PQ, Camarasa MG, Alonso JA, Mendez GF, Feliz FD, Lamela MA, Piñero MV, Alvarado PF, Gómez IL, Martín PF, Gómez JL, López AG, Jiménez AR, Nafs AE, Barquero NC, Ortiz RF, Noguera JL, Carrasco PR, Muñoz JM, Palma MM, Hortelano CM, Bonome LS, Sevilla JS, Juan JM, Ramos JM, Muñoz JL, Guisasola JE, Vazquez LS, Guerras FC, Nebot FJ, Fernández FJ, Nicolau AL, Subirats RC, Kidias MM, Navarro VF, García BF, del Rosal FM, de Vicente Muñoz T, Ballester JA, Lieb PM, Martel AD, Bea ER, Joaquim IG, Enjuanes FB, Piñol MB, Carbonell EF, Muñoz RM, Giribets CA, Sans LA, Blanco AS, Felipe MA, Muñoz PG, Villanueva AP, Arroyo MB, Borri RC, Fallada SM, Merola MC, Rodon EP, Palmes JR, Martínez EP, Catala JM, Coca AS, Ferrandiz FP, Paya EF, Caballero GI, Bonet AF, Figueras JF, Pagador PM, Garibo MM, Camo VP, Carrillo CS, Valero CP, Rebollo FJ, García Campayo J, Sala Ayma JM, Roig MM, de Uña Mateos MA, Bertolin RG, García AM, Mazo FJ, Velasco JL, Pérez LS, Casado CJ, Barba JJ, Diaz MC, Rubio JP, Mandoli AS, Herrero AU, Martínez AR, Serrano PS, Rodríguez EN, Montesinos JS, Macia JF, Mateos Marcos AM, Soto JV, Dumont MV, Pagan JP, Martínez VB, Santiuste de Pablos M, Delgado CE, Quiles MD, López FJ, Navarro PP, Torres AM, Ingles FJ, Arias-Camison JM, Manzano JC, Peña RV, Guitarte GP, Fontecilla HB, Romero JB, Gil RS, Lozano JM, Adanez LD, Zarranz Herrera-Oria I, Jiménez JP, Vaz FC, García OS, Anton CC, Casula RR, Hernandez MC, Escabias FT, Torresano JR, Pérez-Villamil AH, Estevez L, Figuero MA, Muñoz de Morales A, Calvin JL, Criado MD, Rodríguez VM, Ambrosolio EB, Madera PM, Alfaro GP, Vidal MM, Valtuille AG, Ruiz O, Cabornero GL, Echevarria Martínez de Bujo M, Mallen MJ, Puigros JS, Martorell AL, Forteza AC, Arrebola ER, Rodríguez de la Torre M, Saiz CG, Bardolet I Casas C, Linde ER, De Arce Cordon R, Molina EM, Carazo FJ, Romero JJ, Cano DV, Dorado MS, Velazquez SC, Sánchez AJ, Leon SO, Sánchez KP, Benitez MH, Zugarramurai AI, Contreras MA, De la Varga González M, Marín PB, Robina FG, García MS, Pérez FJ, Bros PC, Gómez AC, de Dios Molina Martín J, Perera JL, Averbach MC, Perera JL, Palancares EG, Gallego de Dios MT, Rojo CF, Iglesias SS, Merino MI, Mestre NP, Urdaniz AP, Sánchez JM, Seco RG, Muñoz JF, Agut MM, Lozano ML, Herguedas FM, Pena AT, García JV, Martínez AV, Sanz Granado OS, Fernández MA, Canseco JM, López PA, Martín MA, Barrio JA, Ubago JG, Bennassar MR, Díez JM, Fleta JL, Fortes FP, López CA, Medina O, Alvarez DF, Roca JM, Valladolid GR, Tavera JA, García-Castrillon Sales JA, Llordes IB, Melgarejo CA, Cañas de la Paz F, Callol VV, García MB, García JB, Leal FJ, Corrales EC, Iglesias ES, Gómez MA, Serrano GG, Chillarón EG, Aguado FJ, Castillo JJ, González AG, Vázquez JG, Peralvarez MB, Diaz MR, Mesa MY, Artiles FJ, Chao MA, Mesa MY, del Rosario Santana P, Escudero MA, Berenguer MM, Llacer JM, Berna JA, Ortiz JB, Pardell LT, Hernández-Alvarez de Sotomayor C, Méndez MR, Garate RC, Múgica BD, González MC, Domingo JP, Navarro CS, Vera GS, Cuquerella MA, Monzo JL, Boada PC, Pérez MF, Parrado EC, Sánchez JJ, Fernández JC; e-STAR Spanish Study Group.

Eur Psychiatry. 2009 Jun;24(5):287-96. doi: 10.1016/j.eurpsy.2008.12.002. Epub 2009 Feb 4.

PMID:
19195847
31.

Reactivity of the 4-amino-5H-1,2-oxathiole-2,2-dioxide heterocyclic system: a combined experimental and theoretical study.

de Castro S, Peromingo MT, Lozano AE, Camarasa MJ, Velázquez S.

Chemistry. 2008;14(31):9620-32. doi: 10.1002/chem.200800433.

PMID:
18780390
32.

4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action.

de Castro S, Peromingo MT, Naesens L, Andrei G, Snoeck R, Balzarini J, Velázquez S, Camarasa MJ.

J Med Chem. 2008 Sep 25;51(18):5823-32. doi: 10.1021/jm800050t.

PMID:
18707089
33.

Novel non-nucleoside human cytomegalovirus inhibitors based upon TSAO nucleoside derivatives: structure-activity relationships.

de Castro S, Andrei G, Snoeck R, Balzarini J, Camarasa MJ, Velázquez S.

Nucleosides Nucleotides Nucleic Acids. 2007;26(6-7):625-8.

PMID:
18066868
34.

Carotid atheromatosis in nondiabetic renal transplant recipients: the role of prediabetic glucose homeostasis alterations.

Alvarez A, Fernandez J, Porrini E, Delgado P, Pitti S, Vega MJ, González-Posada JM, Rodríguez A, Pérez L, Marrero D, Luis D, Velázquez S, Hernández D, Salido E, Torres A.

Transplantation. 2007 Oct 15;84(7):870-5.

PMID:
17984840
35.

Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virus.

McGuigan C, Pathirana RN, Migliore M, Adak R, Luoni G, Jones AT, Díez-Torrubia A, Camarasa MJ, Velázquez S, Henson G, Verbeken E, Sienaert R, Naesens L, Snoeck R, Andrei G, Balzarini J.

J Antimicrob Chemother. 2007 Dec;60(6):1316-30. Epub 2007 Oct 22.

PMID:
17956908
36.

Efficient conversion of tetrapeptide-based TSAO prodrugs to the parent drug by dipeptidyl-peptidase IV (DPPIV/CD26).

García-Aparicio C, Diez-Torrubia A, Balzarini J, Lambeir AM, Velázquez S, Camarasa MJ.

Antiviral Res. 2007 Nov;76(2):130-9. Epub 2007 Aug 1.

PMID:
17675255
37.

A cyclic enamine derived from 1,2-O-isopropylidene-alpha-D-xylofuranose as a novel carbohydrate intermediate to achieve skeletal diversity.

Cordeiro A, Quesada E, Bonache MC, Velazquez S, Camarasa MJ, San-Félix A.

J Org Chem. 2006 Sep 15;71(19):7224-35.

PMID:
16958515
38.

Design and discovery of a novel dipeptidyl-peptidase IV (CD26)-based prodrug approach.

García-Aparicio C, Bonache MC, De Meester I, San-Félix A, Balzarini J, Camarasa MJ, Velazquez S.

J Med Chem. 2006 Aug 24;49(17):5339-51.

PMID:
16913724
40.

Dimerization inhibitors of HIV-1 reverse transcriptase, protease and integrase: a single mode of inhibition for the three HIV enzymes?

Camarasa MJ, Velázquez S, San-Félix A, Pérez-Pérez MJ, Gago F.

Antiviral Res. 2006 Sep;71(2-3):260-7. Epub 2006 Jun 28. Review.

PMID:
16872687
41.

Fungal spore diversity of arbuscular mycorrhizal fungi associated with spring wheat: effects of tillage.

Schalamuk S, Velazquez S, Chidichimo H, Cabello M.

Mycologia. 2006 Jan-Feb;98(1):16-22.

PMID:
16800300
42.

Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation.

Porrini E, Delgado P, Bigo C, Alvarez A, Cobo M, Checa MD, Hortal L, Fernández A, García JJ, Velázquez S, Hernández D, Salido E, Torres A.

Am J Kidney Dis. 2006 Jul;48(1):134-42.

PMID:
16797396
43.

TSAO derivatives, inhibitors of HIV-1 reverse transcriptase dimerization: recent progress.

Camarasa MJ, Velázquez S, San-Félix A, Pérez-Pérez MJ, Bonache MC, De Castro S.

Curr Pharm Des. 2006;12(15):1895-907. Review.

PMID:
16724955
44.

Discovery of TSAO derivatives with an unusual HIV-1 activity/resistance profile.

de Castro S, García-Aparicio C, Van Laethem K, Gago F, Lobatón E, De Clercq E, Balzarini J, Camarasa MJ, Velázquez S.

Antiviral Res. 2006 Aug;71(1):15-23. Epub 2006 Mar 29.

PMID:
16616962
45.
46.

Improving the antiviral efficacy and selectivity of HIV-1 reverse transcriptase inhibitor TSAO-T by the introduction of functional groups at the N-3 position.

Bonache MC, Chamorro C, Velázquez S, De Clercq E, Balzarini J, Barrios FR, Gago F, Camarasa MJ, San-Félix A.

J Med Chem. 2005 Oct 20;48(21):6653-60.

PMID:
16220981
47.

TSAO derivatives the first non-peptide inhibitors of HIV-1 RT dimerization.

Camarasa MJ, Velázquez S, San-Félix A, Pérez-Pérez MJ.

Antivir Chem Chemother. 2005;16(3):147-53. Review.

PMID:
16004078
48.

Detailed assessment of microhabitat suitability for Aedes aegypti (Diptera: Culicidae) in Buenos Aires, Argentina.

Vezzani D, Rubio A, Velázquez SM, Schweigmann N, Wiegand T.

Acta Trop. 2005 Aug;95(2):123-31.

PMID:
15993832
49.

The role of Thr139 in the human immunodeficiency virus type 1 reverse transcriptase sensitivity to (+)-calanolide A.

Auwerx J, Rodríguez-Barrios F, Ceccherini-Silberstein F, San-Félix A, Velázquez S, De Clercq E, Camarasa MJ, Perno CF, Gago F, Balzarini J.

Mol Pharmacol. 2005 Sep;68(3):652-9. Epub 2005 Jun 16.

PMID:
15961674
50.

The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.

Auwerx J, Van Nieuwenhove J, Rodríguez-Barrios F, de Castro S, Velázquez S, Ceccherini-Silberstein F, De Clercq E, Camarasa MJ, Perno CF, Gago F, Balzarini J.

FEBS Lett. 2005 Apr 25;579(11):2294-300.

Supplemental Content

Loading ...
Support Center